000 01053 a2200301 4500
005 20250516042655.0
264 0 _c20110708
008 201107s 0 0 eng d
022 _a1107-0625
040 _aNLM
_beng
_cNLM
100 1 _aSahin, I
245 0 0 _aBRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?
_h[electronic resource]
260 _bJournal of B.U.ON. : official journal of the Balkan Union of Oncology
_c
300 _a184-5 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xchemistry
650 0 4 _aFemale
650 0 4 _aGenes, BRCA1
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aPhthalazines
_xtherapeutic use
650 0 4 _aPiperazines
_xtherapeutic use
650 0 4 _aPoly(ADP-ribose) Polymerase Inhibitors
700 1 _aArarat, E
700 1 _aAltundag, K
773 0 _tJournal of B.U.ON. : official journal of the Balkan Union of Oncology
_gvol. 16
_gno. 1
_gp. 184-5
999 _c20929801
_d20929801